TEDCO’s Maryland Innovation Initiative Fund Continues to Deliver Substantial Impact for Maryland Biohealth Companies
The Maryland Technology Development Corporation’s (TEDCO) Maryland Innovation Initiative (MII), a program designed to propel research from partner universities towards commercialization, has had a strong, demonstrable impact on many important life science portfolio companies in the BioHealth Capital Region (BHCR). AsclepiX Therapeutics, Inc., Neuraly/Theraly, NextStep Robotics, Sonavex and Coaptechare just a handful of the latest MII program success stories having achieved […]